New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...
The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
Researchers at UW’s School of Medicine and the Institute for Research in Biomedicine Barcelona may have found an additional ...
Giovanna Prout joins Countable Labs as CEO to accelerate commercialization of Countable Labs’ products Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a ...
"Fueled by advances in NGS and precision medicine, China’s DNA sequencing market sees rapid growth amid strong government support, rising clinical applications, and innovation hubs in Guangdong, ...
Move positions company at the heart of Cambridge's innovation ecosystem to accelerate growth and collaboration in infection prevention.
Visit NGD at Booth #712 to learn more about the NGD system, which automates both sample preparation and bioinformatics, as well as generates actionable reports for Infection Prevention teams.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results